Fiera Capital (Canada)’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
Fiera Capital (Canada)'s TPTX Position: Q3 2022 in Review
Fiera Capital (Canada) sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 30,235 shares — an estimated $2.27M sold.
Fiera Capital (Canada) first reported a position in TPTX in Q4 2019 and held it in 11 quarters. The position peaked at $4.42M in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.
- Fiera Capital (Canada) reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- Fiera Capital (Canada) sold 30,235 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2.27M.
- Fiera Capital (Canada) first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2019 and held it in 11 quarters.
- Fiera Capital (Canada)'s Turning Point Therapeutics, Inc. Common Stock position peaked at $4.42M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.
Based on Fiera Capital (Canada)'s 13F filing for Q3 2022, filed 3 Nov 2022.